Home Applications 203415 Application 203415
Type NDA
Sponsor ASTELLAS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 XTANDI ENZALUTAMIDE CAPSULE;ORAL 40MG Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N203415-001 XTANDI ENZALUTAMIDE 40MG CAPSULE / ORAL RLD, RS 2012-08-31
Orange Book patents# Current patent rows page 1 of 1 · 14 matching rows.
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N203415-001 I-926 2026-11-17
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N203415-001 XTANDI 40MG CAPSULE / ORAL AB RLD, RS 2012-08-31 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N203415-001 XTANDI 40MG CAPSULE / ORAL AB RLD, RS 2012-08-31 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N203415-001 XTANDI 40MG CAPSULE / ORAL AB RLD, RS 2012-08-31 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N203415-001 XTANDI 40MG CAPSULE / ORAL AB RLD, RS 2012-08-31 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N203415-001 XTANDI 40MG CAPSULE / ORAL AB RLD, RS 2012-08-31 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N203415-001 XTANDI 40MG CAPSULE / ORAL AB RLD, RS 2012-08-31 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N203415-001 XTANDI 40MG CAPSULE / ORAL AB RLD, RS 2012-08-31 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N203415-001 XTANDI 40MG CAPSULE / ORAL AB RLD, RS 2012-08-31 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N203415-001 XTANDI 40MG CAPSULE / ORAL RLD, RS 2012-08-31 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N203415-001 XTANDI 40MG CAPSULE / ORAL AB RLD, RS 2012-08-31 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N203415-001 XTANDI 40MG CAPSULE / ORAL AB RLD, RS 2012-08-31 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N203415-001 XTANDI 40MG CAPSULE / ORAL AB RLD, RS 2012-08-31 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N203415-001 XTANDI 40MG CAPSULE / ORAL AB RLD, RS 2012-08-31 cb3db0bc1861…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Patent history page 1 of 10 · 378 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N203415-001 9126941 2026-05-15 U-2345 2015-10-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203415-001 9126941 2026-05-15 U-1588 2015-10-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203415-001 9126941 2026-05-15 U-2708 2015-10-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203415-001 9126941 2026-05-15 U-3763 2015-10-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203415-001 8183274 2026-08-24 U-1281 2012-09-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203415-001 8183274 2026-08-24 U-1588 2012-09-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203415-001 8183274 2026-08-24 U-2708 2012-09-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203415-001 8183274 2026-08-24 U-2345 2012-09-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203415-001 8183274 2026-08-24 U-3763 2012-09-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203415-001 7709517 2027-08-13 Drug substance, Drug product 2012-09-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203415-001 12161628 2037-02-23 U-4101 2025-01-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203415-001 12161628 2037-02-23 U-4102 2025-01-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203415-001 12161628 2037-02-23 U-4103 2025-01-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203415-001 12161628 2037-02-23 U-4104 2025-01-08 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203415-001 9126941 2026-05-15 U-2345 2015-10-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203415-001 9126941 2026-05-15 U-1588 2015-10-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203415-001 9126941 2026-05-15 U-2708 2015-10-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203415-001 9126941 2026-05-15 U-3763 2015-10-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203415-001 8183274 2026-08-24 U-1281 2012-09-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203415-001 8183274 2026-08-24 U-1588 2012-09-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203415-001 8183274 2026-08-24 U-2708 2012-09-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203415-001 8183274 2026-08-24 U-2345 2012-09-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203415-001 8183274 2026-08-24 U-3763 2012-09-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203415-001 7709517 2027-08-13 Drug substance, Drug product 2012-09-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203415-001 12161628 2037-02-23 U-4101 2025-01-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203415-001 12161628 2037-02-23 U-4102 2025-01-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203415-001 12161628 2037-02-23 U-4103 2025-01-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203415-001 12161628 2037-02-23 U-4104 2025-01-08 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N203415-001 9126941 2026-05-15 U-2345 2015-10-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N203415-001 9126941 2026-05-15 U-1588 2015-10-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N203415-001 9126941 2026-05-15 U-2708 2015-10-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N203415-001 9126941 2026-05-15 U-3763 2015-10-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N203415-001 8183274 2026-08-24 U-1281 2012-09-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N203415-001 8183274 2026-08-24 U-1588 2012-09-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N203415-001 8183274 2026-08-24 U-2708 2012-09-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N203415-001 8183274 2026-08-24 U-2345 2012-09-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N203415-001 8183274 2026-08-24 U-3763 2012-09-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N203415-001 7709517 2027-08-13 Drug substance, Drug product 2012-09-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N203415-001 12161628 2037-02-23 U-4101 2025-01-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N203415-001 12161628 2037-02-23 U-4102 2025-01-08 6a471c1ec25d…
Observed Orange Book exclusivity history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 10 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0469-0125 Xtandi enzalutamide Astellas Pharma US, Inc. NDA Current 0469-0125 Xtandi enzalutamide Astellas Pharma US, Inc. NDA Current 0469-0125 Xtandi enzalutamide Astellas Pharma US, Inc. NDA Current 0469-0125 Xtandi enzalutamide Astellas Pharma US, Inc. NDA Current 0469-0125 Xtandi enzalutamide Astellas Pharma US, Inc. NDA Current 0469-0125 Xtandi enzalutamide Astellas Pharma US, Inc. NDA Current 0469-0125 Xtandi enzalutamide Astellas Pharma US, Inc. NDA Current 0469-0125 Xtandi enzalutamide Astellas Pharma US, Inc. NDA Current 0469-1125 Xtandi enzalutamide Astellas Pharma US, Inc. NDA Current 0469-1125 Xtandi enzalutamide Astellas Pharma US, Inc. NDA Current